Influence of Lymphatic, Microvascular and Perineural Invasion on Oncological Outcome in Patients with Neuroendocrine Tumors of the Small Intestine

被引:0
|
作者
Butz, Frederike [1 ,2 ,3 ]
Dukaczewska, Agata [1 ,2 ,3 ]
Kunze, Catarina Alisa [2 ,3 ,4 ]
Kroemer, Janina Maren [1 ,2 ,3 ]
Reinhard, Lisa [1 ,2 ,3 ]
Jann, Henning [2 ,3 ,5 ]
Fehrenbach, Uli [2 ,3 ,6 ]
Mueller-Debus, Charlotte Friederieke [1 ,2 ,3 ]
Skachko, Tatiana [1 ,2 ,3 ]
Pratschke, Johann [1 ,2 ,3 ]
Goretzki, Peter E. [1 ,2 ,3 ]
Mogl, Martina T. [1 ,2 ,3 ]
Dobrindt, Eva Maria [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Campus Virchow Klinikum, Campus Charite Mitte, Dept Surg, D-10117 Berlin, Germany
[2] Free Univ Berlin, D-10117 Berlin, Germany
[3] Humboldt Univ, D-10117 Berlin, Germany
[4] Charite Univ Med Berlin, Dept Pathol, D-10117 Berlin, Germany
[5] Charite Univ Med Berlin, Campus Virchow Klinikum, Campus Charite Mitte, Dept Hepatol & Gastroenterol, D-10117 Berlin, Germany
[6] Charite Univ Med Berlin, Dept Radiol, D-10117 Berlin, Germany
关键词
small-intestinal neuroendocrine tumors; microvascular invasion; lymphatic invasion; perineural invasion; oncological outcome; PROGNOSTIC-FACTORS; VENOUS INVASION; SURVIVAL; SURGERY; DEATH;
D O I
10.3390/cancers16020305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For the histopathological work-up of resected neuroendocrine tumors of the small intestine (siNET), the determination of lymphatic (LI), microvascular (VI) and perineural (PnI) invasion is recommended. Their association with poorer prognosis has already been demonstrated in many tumor entities. However, the influence of LI, VI and PnI in siNET has not been sufficiently described yet. A retrospective analysis of all patients treated for siNET at the ENETS Center of Excellence Charit & eacute;-Universit & auml;tsmedizin Berlin, from 2010 to 2020 was performed (n = 510). Patients who did not undergo primary resection or had G3 tumors were excluded. In the entire cohort (n = 161), patients with LI, VI and PnI status had more distant metastases (48.0% vs. 71.4%, p = 0.005; 47.1% vs. 84.4%, p < 0.001; 34.2% vs. 84.7%, p < 0.001) and had lower rates of curative surgery (58.0% vs. 21.0%, p < 0.001; 48.3% vs. 16.7%, p < 0.001; 68.4% vs. 14.3%, p < 0.001). Progression-free survival was significantly reduced in patients with LI, VI or PnI compared to patients without. This was also demonstrated in patients who underwent curative surgery. Lymphatic, vascular and perineural invasion were associated with disease progression and recurrence in patients with siNET, and these should therefore be included in postoperative treatment considerations.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] ASO Author Reflections: Lymphatic Metastasis of Small Bowel Neuroendocrine Tumors
    Luohai Chen
    Minhu Chen
    Jie Chen
    Annals of Surgical Oncology, 2019, 26 : 555 - 556
  • [42] ASO Author Reflections: Lymphatic Metastasis of Small Bowel Neuroendocrine Tumors
    Chen, Luohai
    Chen, Minhu
    Chen, Jie
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S555 - S556
  • [43] Lymphovascular Invasion is a Bad Actor in Small Bowel Neuroendocrine Tumors
    De Andrade, J.
    Blakely, A. M.
    Nguyen, A. H.
    Ituarte, P.
    Li, D.
    Lee, B.
    Singh, G.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S201 - S201
  • [44] Small Intestine Neuroendocrine Tumors: Frequently of Unrecognized Primary Site and Multifocal
    Javeed, Zafir
    Wang, Yucheng
    Donner, David B.
    Bergsland, Emily K.
    Warren, Robert S.
    Nakakura, Eric K.
    PANCREAS, 2015, 44 (02) : 353 - 354
  • [45] Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors
    Perez, Kimberly
    Kulke, Matthew
    Brais, Lauren
    Gadgil, Rujuta
    Alexander, Holly
    Nowak, Jonathan
    Garcia, John
    Yang, Shan
    Esplin, Ed
    Syngal, Sapna
    Garber, Judy
    Chan, Jennifer
    PANCREAS, 2020, 49 (03) : 482 - 483
  • [46] Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
    Dirk Walter
    Patrick N. Harter
    Florian Battke
    Ria Winkelmann
    Markus Schneider
    Katharina Holzer
    Christine Koch
    Jörg Bojunga
    Stefan Zeuzem
    Martin Leo Hansmann
    Jan Peveling-Oberhag
    Oliver Waidmann
    Scientific Reports, 8
  • [47] Whole Exome Sequencing of Three Families with Small Intestine Neuroendocrine Tumors
    Beyens, M.
    Vandamme, T.
    Goepfert, A.
    Van Camp, G.
    Hofland, L.
    Peeters, M.
    De Herder, W.
    de Beeck, Op K.
    NEUROENDOCRINOLOGY, 2016, 103 : 5 - 5
  • [48] EVALUATION OF THE EXPRESSION OF SOMATOSTATIN RECEPTORS BY IMMUNOHISTOCHEMISTRY IN NEUROENDOCRINE TUMORS OF THE SMALL INTESTINE
    Gut, Pawel
    Czarnywojtek, Agata
    Sawicka-Gutaj, Nadia
    Wolinski, Kosma
    Janicka-Jedynska, Malgorzata
    Bednarek-Rajewska, Katarzyna
    Furman, Katarzyna
    Fichna, Marta
    Ruchala, Marek
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (01) : 30 - 37
  • [49] Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
    Walter, Dirk
    Harter, Patrick N.
    Battke, Florian
    Winkelmann, Ria
    Schneider, Markus
    Holzer, Katharina
    Koch, Christine
    Bojunga, Joerg
    Zeuzem, Stefan
    Hansmann, Martin Leo
    Peveling-Oberhag, Jan
    Waidmann, Oliver
    SCIENTIFIC REPORTS, 2018, 8
  • [50] Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains
    Nieser, Maike
    Henopp, Tobias
    Brix, Joachim
    Stoss, Laura
    Sitek, Barbara
    Naboulsi, Wael
    Anlauf, Martin
    Schlitter, Anna M.
    Kloppel, Gunter
    Gress, Thomas
    Moll, Roland
    Bartsch, Detlef K.
    Heverhagen, Anna E.
    Knoefel, Wolfram T.
    Kaemmerer, Daniel
    Haybaeck, Johannes
    Fend, Falko
    Sperveslage, Jan
    Sipos, Bence
    NEUROENDOCRINOLOGY, 2017, 104 (03) : 302 - 312